Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

The World Health Organization HCV Guideline Development Group is considering a “treat
all” recommendation for persons infected with hepatitis C virus (HCV). We reviewed the …

The development of direct-acting antiviral agents that can cure a chronic hepatitis C virus
(HCV) infection after 8–12 weeks of daily, well-tolerated therapy has revolutionized the …

Background The universal treatment of diagnosed patients with chronic HCV infection has
been widely conducted in Italy since 2017. However, the pool of individuals diagnosed but …

Background Elimination of hepatitis C virus (HCV) infection requires high diagnostic rates
and universal access to treatment. Around 40% of infected individuals are unaware of their …

This study provides an update on hepatitis C virus (HCV) estimates across Italy up to
January 2021. A mathematical probabilistic modelling approach, including a Markov chain …

Background Although an increase in hepatitis C virus (HCV) prevalence from Northern to
Southern Italy has been reported, the burden of asymptomatic individuals in different Italian …

Increasing injection of heroin and prescription opioids have led to increases in the incidence
of hepatitis C virus (HCV) infections in US young adults since the early 2000s. How best to …

Abstract Background and Aims Italy has the greatest burden of hepatitis C virus (HCV)
infection in Western Europe. The screening strategy represents a crucial prevention tool to …

Objective We estimated the cost consequence of Italian National Health System (NHS)
investment in direct-acting antiviral (DAA) therapy according to hepatitis C virus (HCV) …